Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Other Stockholders Equity : $0.70 Mil (As of Jan. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Other Stockholders Equity?

Cotinga Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Jan. 2020 was $0.70 Mil.

Cotinga Pharmaceuticals's quarterly Other Stockholders Equity declined from Jul. 2019 ($0.80 Mil) to Oct. 2019 ($0.78 Mil) and declined from Oct. 2019 ($0.78 Mil) to Jan. 2020 ($0.70 Mil).

Cotinga Pharmaceuticals's annual Other Stockholders Equity declined from Apr. 2017 ($0.87 Mil) to Apr. 2018 ($0.63 Mil) but then increased from Apr. 2018 ($0.63 Mil) to Apr. 2019 ($0.71 Mil).

Cotinga Pharmaceuticals Other Stockholders Equity Historical Data

The historical data trend for Cotinga Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Other Stockholders Equity Chart

Cotinga Pharmaceuticals Annual Data

Trend

Apr10

Apr11

Apr12

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Other Stockholders Equity

Get a 7-Day Free Trial

4.76

1.12

0.87

0.63

0.71

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Other Stockholders Equity	Get a 7-Day Free Trial															0.70	0.71	0.80	0.78	0.70

Cotinga Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Cotinga Pharmaceuticals Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018